[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353672-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353672-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cardenolide-engineered-extracellular-vesicles-augment-drug-uptake-and-cytotoxicity-in-non-small-cell-lung-cancer-cells","Cardenolide-Engineered Extracellular Vesicles Augment Drug Uptake and Cytotoxicity in Non-small Cell Lung Cancer Cells","","Cancer causes substantial premature mortality worldwide, making selective targeted drug delivery essential to attack malignant cells while sparing healthy tissue and lowering required doses. The sodium–potassium ATPase (Na+/K+-ATPase), especially its catalytic α-subunit, is overexpressed in A549 non-small cell lung cancer (NSCLC) cells and represents a therapeutic target. Cardiac glycosides bind and inhibit this enzyme. This study links a cardenolide derivative (3β-azido-3-deoxydigitoxigenin) to A549 cell-derived extracellular vesicles (EVs), characterizes the conjugates, verifies Na+/K+-ATPase inhibition and confocal co-localization, and shows doxorubicin-loaded EVs reduce A549 viability to 45% after 48 h.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cardenolide-engineered-extracellular-vesicles-augment-drug-uptake-and-cytotoxicity-in-non-small-cell-lung-cancer-cells/353672/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cardenolide-engineered-extracellular-vesicles-augment-drug-uptake-and-cytotoxicity-in-non-small-cell-lung-cancer-cells/353672.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is Na+/K+-ATPase considered a target in A549 non-small cell lung cancer cells?","Question",{"text":63,"@type":64},"Na+/K+-ATPase, particularly its catalytic α-subunit, is overexpressed in A549 NSCLC cells, making it a potential therapeutic target for selective inhibition.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were cardenolide-engineered extracellular vesicles prepared and modified?",{"text":68,"@type":64},"A semi-synthetic cardenolide derivative (3β-azido-3-deoxydigitoxigenin) was linked to the surface of A549 cell-derived EVs, with surface modification achieved via alkyne modification and click chemistry, and conjugation confirmed by Na+/K+-ATPase activity inhibition.",{"name":70,"@type":61,"acceptedAnswer":71},"What was the impact on A549 cell viability when using doxorubicin-loaded, CA-modified EVs?",{"text":72,"@type":64},"Doxorubicin-loaded, CA-modified EVs reduced A549 cell viability to 45% after 48 hours, indicating potential as a new drug nanocarrier system.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353672,1790493737,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":118,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Small Methods   \n[www.small-methods.com](www.small-methods.com)  \n RESEARCH ARTICLE   \nCardenolide-Engineered Extracellular Vesicles Augment Drug Uptake and Cytotoxicityin Non-small Cell Lung Cancer Cells  \nMaja Dorfner1   Anika Mifka1  Rodrigo Maia de Pádua3   Izabella Thaís da Silva4   Iara Zanella Guterres4   Lorenzo Sana1  Gregor Fuhrmann1, 2   Jennifer Munkert1, 2   \n1 Pharmaceutical Biology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany  2 FAU NeW, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany  3 Department of Pharmaceutical Products, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil   \n4 Department of Pharmaceutical Sciences, Federal University Santa Catarina, Florianopolis, SC, Brazil Correspondence: Jennifer Munkert ([jennifer.munkert@fau.de](jennifer.munkert@fau.de))  \nReceived: 30 July 2025  Revised: 27 November 2025  Accepted: 9 December 2025  \nKeywords: cardenolide derivative 3β-azido-3-deoxydigitoxigenin | Na+ /K+ -ATPase inhibition assay | surface-modification by click chemistry | target drug delivery | A549 non-small cell lung cancer (NSCLC) cell line  \nABSTRACT  \nCancer remains a leading cause of premature mortality worldwide. Targeted drug delivery therapies that selectively attack malignant cells while sparing healthy tissue are essential to minimize side effects and reduce drug dosages. The sodium-potassium ATPase (Na+ /K+ -ATPase), particularly its catalytic α-subunit, is overexpressed in A549 non-small cell lung cancer (NSCLC) and has thus emerged as a potential therapeutic target. Cardiac glycosides (CGs), plant-derived secondary metabolites, specifically bind and inhibit this enzyme providing target engagement. Coupling CGs to a biocompatible carrier provides a promising new approach for a targeted-orientated drug carrier. Among these nanocarrier systems, cell-derived extracellular vesicles (EVs) gained attention due to their biocompatibility, tumor-targeting capability, and ability to encapsulate compounds. Here, we developed a target-oriented nanocarrier system by linking 3β-azido-3-deoxydigitoxigenin (CA), a semi-synthetic cardenolide derivative, to the surface of A549 cell-derived EVs. The EVs were characterized for particle concentration, size and protein markers. Surface modification was achieved via alkyne modification and click chemistry. Successful conjugation was confirmed by inhibition of the Na+ /K+ -ATPase activity. Co-localization of CA-modified EVs with the Na+ /K+ -ATPase was verified by confocal microscopy. Doxorubicin-loaded, CA-modified EVs reduced A549 cell viability to 45% after 48 h, demonstrating its potential use as new drug nanocarrier system.  \n1  Introduction  \nCancer is a significant global public health challenge with yearly approximately 20 million new cases and 10 million deaths [1] . Despite extensive efforts, the number of newly diagnosed cancer cases are increasing yearly. One out of five people are estimated to develop cancer in their lifetime, with lung cancer having the highest morbidity and mortality rate [1] . Over the years, cancer  \ntreatment has innovated from conventional chemotherapy and radiation to targeted therapies, immunotherapy, personalized medicine, and nanotechnology-driven drug delivery, improving specificity, efficacy, and patient outcomes [2] .  \nIn general, cancer treatment strategies increasingly focus on identifying molecular and physiological differences between cancer cells and normal cells to achieve targeted therapeutic effects.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Small Methods published by Wiley-VCH GmbH  \nSmall Methods, 2026; 10:e01505  \n[https://doi.org/10.1002/smtd.202501505](https://doi.org/10.1002/smtd.202501505)  \n1 of 20  \nUtilizing these specific differences allows for selective inhibition","cbCaiuXAxu7ru46d","https://ap.wps.com/l/cbCaiuXAxu7ru46d","pdf",4758061,"English","# Abstract\n## Introduction\n## Na+/K+-ATPase as a therapeutic target","[{\"question\":\"Why is Na+/K+-ATPase considered a target in A549 non-small cell lung cancer cells?\",\"answer\":\"Na+/K+-ATPase, particularly its catalytic α-subunit, is overexpressed in A549 NSCLC cells, making it a potential therapeutic target for selective inhibition.\"},{\"question\":\"How were cardenolide-engineered extracellular vesicles prepared and modified?\",\"answer\":\"A semi-synthetic cardenolide derivative (3β-azido-3-deoxydigitoxigenin) was linked to the surface of A549 cell-derived EVs, with surface modification achieved via alkyne modification and click chemistry, and conjugation confirmed by Na+/K+-ATPase activity inhibition.\"},{\"question\":\"What was the impact on A549 cell viability when using doxorubicin-loaded, CA-modified EVs?\",\"answer\":\"Doxorubicin-loaded, CA-modified EVs reduced A549 cell viability to 45% after 48 hours, indicating potential as a new drug nanocarrier system.\"}]","Cardenolide-Engineered Extracellular Vesicles Augment Drug Uptake and Cytotoxicity in Non-small Cell Lung Cancer Cells | PDF",1790106665,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52bbc126ce71d4619744047ffd1d10e7.webp",983,1291,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/284f5633f6741d4c224658bef703977a.webp",982,1290,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68898c963dbda7df08c2f46fe3ff83ff.webp",981,1289,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88710eb4b36b1509d1f5f1bc6e2a50ae.webp",980,1287]